Control study of paroxetine and imipramine in the treatment of depression
Ran Jiang-feng
Abstract
Ran Jiang-feng
Abstract
Objective:To evaluate the efficacy and safety of paroxetine in the treatment of depression.Methods:63 patients with depression were randomly divided into the treatment groups of paroxetine or imipramine for 6 weeks.HAMD were adopted to evaluate the therapeutie effect.TESS was used to assess the side effects.Results:The effective rate in paroxetine group was 87.5%.No significant difference was found between the two groups.The adverse efffects of paroxetine were less and mild.Conclusions:Paroxetine is an effective antidepressant in treating depression.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To evaluate the efficacy and safety of paroxetine in the treatment of depression.Methods:63 patients with depression were randomly divided into the treatment groups of paroxetine or imipramine for 6 weeks.HAMD were adopted to evaluate the therapeutie effect.TESS was used to assess the side effects.Results:The effective rate in paroxetine group was 87.5%.No significant difference was found between the two groups.The adverse efffects of paroxetine were less and mild.Conclusions:Paroxetine is an effective antidepressant in treating depression.
Key concepts: Paroxetine, Imipramine, Hamd, Depression (economics), Antidepressant, Significant difference, Medicine, Adverse effect